Reports
Sale
Latin America Stem Cell Assay Market Size, Share, Growth: By Cell Type: Adult Stem Cells, Human Embryonic Stem Cells, Pluripotent; By Type: Viability /Cytotoxicity Assays, Isolation & Purification Assays, Others; By Product & Service; By Treatment; By Application; By End User; Regional Analysis; Supplier Landscape; 2024-2032
Latin America Stem Cell Assay Market Size
The global stem cell assay market was valued at USD 6.4 billion in 2023, with Latin America holding a significant market share. It is expected to grow at a CAGR of 13.18% during the forecast period of 2024-2032. The market is poised to secure a market value of USD 19.4 billion by 2032, driven by the rising fundings to conduct stem cell research activities in the region.
Latin America Stem Cell Assay Market Outlook
- The market is significantly impacted by rising application stem cell assays to treat chronic conditions like lymphoma, which a high incidence in the Latin American region.
- Changes in regulatory landscape is likely to boost the market value for stem cell assays in the region.
- Technological advancements such as improvements in product design and adavces in portability are expected to boost the market demand significantly.
Latin America Stem Cell Assay Market Analysis
Stem cell assays are lab techniques that help in examining the characteristics, behavior, and properties of stem cells. These cells have features such as self-renewal and the power to differentiate between various specialised cells. Stem cell assays are used in various domains such as basic research, drug discovery, toxicity screening, disease modelling, and regenerative medicine, among others.
The market has been witnessing multiple trends that can potentially contribute to market growth. It includes increasing research activities to explore more applications of stem cell assays in healthcare. The market is expected to be driven by technological advancements to ensure better outcomes through stem cell assays. Moreover, the government establishing new regulations in selected countries to perform scientific research, likely to boost the Latin America stem cell assay market growth in the forecast period.
In February 2024, the International Agency for Research on Cancer (IARC) released a new study which revealed that children aged 0–14 years in Latin America and the Caribbean have a higher incidence of lymphoma compared with the combined global data. The market is experiencing an increased demand for stem cell assays to develop therapies to treat particular medical conditions with no apparent cure in the healthcare domain. The increasing demand for personalised medicine and the use of stem cell assays in the development of regenerative medicine is boosting the Latin America stem cell assay market demand.
The market value is poised to be driven by evolving regulatory rules by the government. In December 2023, Law Library released its report that provided ample clarity on regulatory landscapes in several Latin American countries. Regulatory clarity can create a predictable environment for researchers and businesses, enabling them to plan and conduct their activities with a better understanding which may also attract more investment into stem cell research and related assays in the region contributing to a boost to the Latin America stem cell assay market share.
The market is further driven by the integration of innovation techniques with stem cell therapies that eventually improve its efficacy such as tissue engineering, biomaterial scaffolds, and gene editing. These advancements hold great promise for improving treatment outcomes and the long-term success of stem cell therapies.
Latin America Stem Cell Assay Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Cell Type | Adult Stem Cells, Human Embryonic Stem Cells, Pluripotent |
| Type | Viability /Cytotoxicity Assays, Isolation and Purification Assays, Cell Identification Assays, Proliferation Assays, Differentiation Assays, Function Assays, Apoptosis Assays, Others |
| Product and Services | Flow Cytometers, Cell Imaging & Analysis Systems, Microelectrode Arrays, Automated Cell Counters, Kits |
| Treatment | Allogeneic Stem Cell Therapy, Autologic Stem Cell Therapy, Syngeneic Stem Cell Therapy |
| Application | Regenerative Medicine & Therapy Development, Drug Discovery & Development, Clinical Research, Others |
| End User | Biopharmaceutical, Biotechnology Companies, Academic and Research Institutes, Others |
| Country | Brazil, Argentina, Mexico, Others |
Leading Players in the Latin America Stem Cell Assay Market
The key features of the market report include partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Thermo Fisher Scientific
- PerkinElmer
- Stemcell Technologies
- Merck
- Bio-Rad Laboratories
- Agilent Technologies
- Promega
- Bio-Techne
- Cell Biolabs
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Cell Type |
|
| Breakup by Type |
|
| Breakup by Product & Service |
|
| Breakup by Treatment |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Latin America Stem Cell Assay Market Overview
3.1 Latin America Stem Cell Assay Market Historical Value (2017-2023)
3.2 Latin America Stem Cell Assay Market Forecast Value (2024-2032)
4 Latin America Stem Cell Assay Market Landscape*
4.1 Latin America Stem Cell Assay: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Latin America Stem Cell Assay: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Cell Type
4.2.3 Analysis by Treatment
5 Latin America Stem Cell Assay Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Latin America Stem Cell Assay Market Segmentation (2017-2032)
6.1 Latin America Stem Cell Assay Market (2017-2032) by Cell Type
6.1.1 Market Overview
6.1.2 Adult Stem Cells
6.1.3 Human Embryonic Stem Cells
6.1.4 Pluripotent
6.2 Latin America Stem Cell Assay Market (2017-2032) by Type
6.2.1 Market Overview
6.2.2 Viability /Cytotoxicity Assays
6.2.3 Isolation & Purification Assays
6.2.4 Cell Identification Assays
6.2.5 Proliferation Assays
6.2.6 Differentiation Assays
6.2.7 Function Assays
6.2.8 Apoptosis Assays
6.2.9 Others
6.3 Latin America Stem Cell Assay Market (2017-2032) by Product & Service
6.3.1 Market Overview
6.3.2 Flow Cytometers
6.3.3 Cell Imaging & Analysis Systems
6.3.4 Microelectrode Arrays
6.3.5 Automated Cell Counters
6.3.6 Kits
6.4 Latin America Stem Cell Assay Market (2017-2032) by Treatment
6.4.1 Market Overview
6.4.2 Allogeneic Stem Cell Therapy
6.4.3 Autologic Stem Cell Therapy
6.4.4 Syngeneic Stem Cell Therapy
6.5 Latin America Stem Cell Assay Market (2017-2032) by Application
6.5.1 Market Overview
6.5.2 Regenerative Medicine & Therapy Development
6.5.3 Drug Discovery & Development
6.5.4 Clinical Research
6.5.5 Others
6.6 Latin America Stem Cell Assay Market (2017-2032) by End User
6.6.1 Market Overview
6.6.2 Biopharmaceutical & Biotechnology Companies
6.6.3 Academic & Research Institutes
6.6.4 Others
6.7 Latin America Stem Cell Assay Market (2017-2032) by Countries
6.7.1 Market Overview
6.7.2 Brazil
6.7.3 Argentina
6.7.4 Mexico
6.7.5 Others
7 Brazil of Stem Cell Assay Market (2017-2032)
7.1 Brazil Stem Cell Assay Market (2017-2032) by Cell Type
7.1.1 Market Overview
7.1.2 Adult Stem Cells
7.1.3 Human Embryonic Stem Cells
7.1.4 Pluripotent
7.2 Brazil Stem Cell Assay Market (2017-2032) by Type
7.2.1 Market Overview
7.2.2 Viability /Cytotoxicity Assays
7.2.3 Isolation & Purification Assays
7.2.4 Cell Identification Assays
7.2.5 Proliferation Assays
7.2.6 Differentiation Assays
7.2.7 Function Assays
7.2.8 Apoptosis Assays
7.2.9 Others
7.3 Brazil Stem Cell Assay Market (2017-2032) by Product & Service
7.3.1 Market Overview
7.3.2 Flow Cytometers
7.3.3 Cell Imaging & Analysis Systems
7.3.4 Microelectrode Arrays
7.3.5 Automated Cell Counters
7.3.6 Kits
7.4 Brazil Stem Cell Assay Market (2017-2032) by Treatment
7.4.1 Market Overview
7.4.2 Allogeneic Stem Cell Therapy
7.4.3 Autologic Stem Cell Therapy
7.4.4 Syngeneic Stem Cell Therapy
7.5 Brazil Stem Cell Assay Market (2017-2032) by Application
7.5.1 Market Overview
7.5.2 Regenerative Medicine &Therapy Development
7.5.3 Drug Discovery & Development
7.5.4 Clinical Research
7.5.5 Others
7.6 Brazil America Stem Cell Assay Market (2017-2032) by End User
7.6.1 Market Overview
7.6.2 Biopharmaceutical & Biotechnology Companies
7.6.3 Academic & Research Institutes
7.6.4 Others
8 Argentina Stem Cell Assay Market (2017-2032)
8.1 Argentina Stem Cell Assay Market (2017-2032) by Cell Type
8.1.1 Market Overview
8.1.2 Adult Stem Cells
8.1.3 Human Embryonic Stem Cells
8.1.4 Pluripotent
8.2 Argentina Stem Cell Assay Market (2017-2032) by Type
8.2.1 Market Overview
8.2.2 Viability /Cytotoxicity Assays
8.2.3 Isolation & Purification Assays
8.2.4 Cell Identification Assays
8.2.5 Proliferation Assays
8.2.6 Differentiation Assays
8.2.7 Function Assays
8.2.8 Apoptosis Assays
8.2.9 Others
8.3 Argentina Stem Cell Assay Market (2017-2032) by Product & Service
8.3.1 Market Overview
8.3.2 Flow Cytometers
8.3.3 Cell Imaging & Analysis Systems
8.3.4 Microelectrode Arrays
8.3.5 Automated Cell Counters
8.3.6 Kits
8.4 Argentina Stem Cell Assay Market (2017-2032) by Treatment
8.4.1 Market Overview
8.4.2 Allogeneic Stem Cell Therapy
8.4.3 Autologic Stem Cell Therapy
8.4.4 Syngeneic Stem Cell Therapy
8.5 Argentina Stem Cell Assay Market (2017-2032) by Application
8.5.1 Market Overview
8.5.2 Regenerative Medicine &Therapy Development
8.5.3 Drug Discovery & Development
8.5.4 Clinical Research
8.6 Argentina Stem Cell Assay Market (2017-2032) by End User
8.6.1 Market Overview
8.6.2 Biopharmaceutical & Biotechnology Companies
8.6.3 Academic & Research Institutes
8.6.4 Others
9 Mexico Stem Cell Assay Market (2017-2032)
9.1 Mexico Stem Cell Assay Market (2017-2032) by Cell Type
9.1.1 Market Overview
9.1.2 Adult Stem Cells
9.1.3 Human Embryonic Stem Cells
9.1.4 Pluripotent
9.2 Mexico Stem Cell Assay Market (2017-2032) by Type
9.2.1 Market Overview
9.2.2 Viability /Cytotoxicity Assays
9.2.3 Isolation & Purification Assays
9.2.4 Cell Identification Assays
9.2.5 Proliferation Assays
9.2.6 Differentiation Assays
9.2.7 Function Assays
9.2.8 Apoptosis Assays
9.2.9 Others
9.3 Mexico Stem Cell Assay Market (2017-2032) by Product & Service
9.3.1 Market Overview
9.3.2 Flow Cytometers
9.3.3 Cell Imaging & Analysis Systems
9.3.4 Microelectrode Arrays
9.3.5 Automated Cell Counters
9.3.6 Kits
9.4 Mexico Stem Cell Assay Market (2017-2032) by Treatment
9.4.1 Market Overview
9.4.2 Allogeneic Stem Cell Therapy
9.4.3 Autologic Stem Cell Therapy
9.4.4 Syngeneic Stem Cell Therapy
9.5 Mexico Stem Cell Assay Market (2017-2032) by Application
9.5.1 Market Overview
9.5.2 Regenerative Medicine &Therapy Development
9.5.3 Drug Discovery & Development
9.5.4 Clinical Research
9.5.5 Others
9.6 Mexico Stem Cell Assay Market (2017-2032) by End User
9.6.1 Market Overview
9.6.2 Biopharmaceutical & Biotechnology Companies
9.6.3 Academic & Research Institutes
9.6.4 Others
10 Regulatory Framework
11 Partnership and Collaborations Analysis
11.1 Analysis by Partnership Instances
11.2 Analysis by Type of Partnership
11.3 Analysis by Leading Players
11.4 Analysis by Geography
12 Supplier Landscape
12.1 Market Share by Top 5 Companies
12.2 Thermo Fisher Scientific
12.2.1 Financial Analysis
12.2.2 Product Portfolio
12.2.3 Demographic Reach and Achievements
12.2.4 Mergers and Acquisitions
12.2.5 Certifications
12.3 PerkinElmer
12.3.1 Financial Analysis
12.3.2 Product Portfolio
12.3.3 Demographic Reach and Achievements
12.3.4 Mergers and Acquisitions
12.3.5 Certifications
12.4 Stemcell Technologies
12.4.1 Financial Analysis
12.4.2 Product Portfolio
12.4.3 Demographic Reach and Achievements
12.4.4 Mergers and Acquisitions
12.4.5 Certifications
12.5 Merck
12.5.1 Financial Analysis
12.5.2 Product Portfolio
12.5.3 Demographic Reach and Achievements
12.5.4 Mergers and Acquisitions
12.5.5 Certifications
12.6 Bio-Rad Laboratories
12.6.1 Financial Analysis
12.6.2 Product Portfolio
12.6.3 Demographic Reach and Achievements
12.6.4 Mergers and Acquisitions
12.6.5 Certifications
12.7 Agilent Technologies
12.7.1 Financial Analysis
12.7.2 Product Portfolio
12.7.3 Demographic Reach and Achievements
12.7.4 Mergers and Acquisitions
12.7.5 Certifications
12.8 Promega
12.8.1 Financial Analysis
12.8.2 Product Portfolio
12.8.3 Demographic Reach and Achievements
12.8.4 Mergers and Acquisitions
12.8.5 Certifications
12.9 Bio-Techne
12.9.1 Financial Analysis
12.9.2 Product Portfolio
12.9.3 Demographic Reach and Achievements
12.9.4 Mergers and Acquisitions
12.9.5 Certifications
12.10 Cell Biolabs
12.10.1 Financial Analysis
12.10.2 Product Portfolio
12.10.3 Demographic Reach and Achievements
12.10.4 Mergers and Acquisitions
12.10.5 Certifications
13 Latin America Stem Cell Assay Market – Distribution Model (Additional Insight)
13.1 Overview
13.2 Potential Distributors
13.3 Key Parameters for Distribution Partner Assessment
14 Key Opinion Leaders (KOL) Insights (Additional Insight)
15 Company Competitiveness Analysis (Additional Insight)
15.1 Very Small Companies
15.2 Small Companies
15.3 Mid-Sized Companies
15.4 Large Companies
15.5 Very Large Companies
16 Payment Methods (Additional Insight)
16.1 Government Funded
16.2 Private Insurance
16.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The Latin America stem cell market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 13.18% during the forecast period of 2024-2032 and is likely to reach a market value of USD 19.4 billion by 2032.
The market is driven by the increasing improvements in the healthcare infrastructure along with increasing research activities in the region.
Increased application of stem cells in drug discovery and development, along with technological advancements in the assay design is one of the major market trends.
Adult stem cells, human embryonic stem cells, and pluripotent are major cell types available in the market.
Based on types, the market is divided into viability/cytotoxicity assays, isolation and purification assays, cell identification assays, proliferation assays, differentiation assays, function assays, apoptosis assays, and others.
Products and services include flow cytometers, cell imaging and analysis systems, microelectrode arrays, automated cell counters, and kits.
There are treatments such as allogeneic stem cell therapy, autologic stem cell therapy, and syngeneic stem cell therapy.
Common application areas of stem cell assay include regenerative medicine and therapy development, drug discovery and development, and clinical research, among others.
Major end users include biopharmaceutical and biotechnology companies, academic and research institutes, among others.
The market segmentation by countries includes Brazil, Argentina, Mexico, and others.
The key players in the market are Thermo Fisher Scientific, PerkinElmer, Stemcell Technologies, Merck, Bio-Rad Laboratories, Agilent Technologies, Promega, Bio-Techne and Cell Biolabs.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2639
$2399
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 4399
$3999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 5829
$5299
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 6929
$6299
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER